JPRN-UMIN000011753已完成未知
Clinical Trial for Immunostimulating effect of Physta(R)/Eurycoma Longifolia Extract - A Randomized Controlled Trial. - Clinical Trial for Immunostimulating effect of Physta(R)/Eurycoma Longifolia Extract
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 80
研究概览
简要总结
George A, Suzuki N, Abas AB, Mohri K, Utsuyama M, Hirokawa K, Takara T. Immunomodulation in Middle-Aged Humans Via the Ingestion of Physta Standardized Root Water Extract of Eurycoma longifolia Jack-A Randomized, Double-Blind, Placebo-Controlled, Parallel Study. Phytother Res. 2016; 30(4): 627-35.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40years-old 至 59years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •a) Persons who have previous medical history of heart failure and cardiacinfarction b) Patients being treated for arterial fibrillation, cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, dyslipidemia, hypertension, and other chronic disease c) Persons who takes medicines, herbal medicines, and dietary supplements within 30 days d) Persons who has allergy e) Pregnant women, lactating women, or women who want to get pregnant during the trial period f) Pollinosis patients g) Smokers h) Persons who enrolled in the other clinical trials within last 3 months before the agreement for the participation to the trial i) Persons who investigator judge not suitable to participate in the trial
研究者
相似试验
已完成
不适用
A study for evaluating the immunostimulating effect -A Randomized, double-blind, placebo controlled trial.Healthy adults who feel fatigueJPRN-UMIN000021989ORTHOMEDICO, Inc.40
尚未招募
Unknown
EFFECT Trial: Evaluating Fermentable Fibre as a Long COVID TherapyACTRN12624000356561Monash University40
已完成
Unknown
A confirmation study of the immunostimulating effect of beekeeping products intake in healthy subjectsAdultJPRN-UMIN000050822Yamada Bee Company, Inc.64
已完成
不适用
ipid emulsion (drug) in Acute on Chronic Liver Failure (Liver Disease).CTRI/2018/04/012995Institute of liver and Biliary Sciences90
终止
1 期
Poly ICLC, Radiation, and Romidepsin for Advanced Cutaneous T Cell LymphomaCutaneous T-cell LymphomaNCT02061449NYU Langone Health3
